PTPRM
Basic information
Region (hg38): 18:7566782-8406861
Previous symbols: [ "PTPRL1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTPRM gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 14 | 25 | |||
missense | 54 | 57 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 1 | 4 | |||
non coding | 2 | |||||
Total | 0 | 0 | 54 | 14 | 16 |
Variants in PTPRM
This is a list of pathogenic ClinVar variants found in the PTPRM region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-7567838-G-T | not specified | Uncertain significance (Mar 31, 2024) | ||
18-7774150-T-C | PTPRM-related disorder | Likely benign (Feb 20, 2019) | ||
18-7774173-A-G | not specified | Uncertain significance (Feb 17, 2022) | ||
18-7774192-T-A | PTPRM-related disorder | Benign (Dec 31, 2019) | ||
18-7774210-C-T | Benign (Oct 09, 2018) | |||
18-7774215-A-G | not specified | Uncertain significance (Aug 17, 2022) | ||
18-7774222-G-A | PTPRM-related disorder | Likely benign (Apr 11, 2019) | ||
18-7774241-A-G | not specified | Uncertain significance (Jan 26, 2022) | ||
18-7888117-C-A | not specified | Uncertain significance (Jul 09, 2021) | ||
18-7888226-A-G | not specified | Uncertain significance (Mar 25, 2024) | ||
18-7888232-A-G | not specified | Uncertain significance (Jul 05, 2023) | ||
18-7888286-G-A | not specified | Uncertain significance (Dec 16, 2022) | ||
18-7888308-T-C | PTPRM-related disorder | Likely benign (Mar 08, 2019) | ||
18-7888316-C-A | not specified | Uncertain significance (Nov 21, 2023) | ||
18-7888331-A-G | not specified | Uncertain significance (Oct 03, 2022) | ||
18-7888339-G-C | not specified | Uncertain significance (Apr 08, 2024) | ||
18-7906539-G-C | not specified | Uncertain significance (Dec 15, 2023) | ||
18-7906550-A-G | not specified | Uncertain significance (Jul 06, 2022) | ||
18-7906562-A-C | not specified | Uncertain significance (May 24, 2023) | ||
18-7926574-C-G | not specified | Uncertain significance (Mar 19, 2024) | ||
18-7926614-T-C | PTPRM-related disorder | Likely benign (May 21, 2019) | ||
18-7949172-T-C | PTPRM-related disorder | Benign/Likely benign (Jun 25, 2018) | ||
18-7949256-G-A | not specified | Uncertain significance (Apr 20, 2024) | ||
18-7949277-G-A | not specified | Uncertain significance (Dec 19, 2023) | ||
18-7949292-C-T | not specified | Uncertain significance (Feb 12, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PTPRM | protein_coding | protein_coding | ENST00000580170 | 33 | 840080 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000198 | 125667 | 0 | 81 | 125748 | 0.000322 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.84 | 616 | 849 | 0.725 | 0.0000478 | 9613 |
Missense in Polyphen | 169 | 333.59 | 0.50661 | 3788 | ||
Synonymous | -0.566 | 330 | 317 | 1.04 | 0.0000189 | 2809 |
Loss of Function | 7.25 | 12 | 83.4 | 0.144 | 0.00000463 | 918 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000206 | 0.000206 |
Ashkenazi Jewish | 0.00536 | 0.00537 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000465 | 0.0000462 |
European (Non-Finnish) | 0.000114 | 0.000114 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000981 | 0.0000980 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in cell-cell adhesion through homophilic interactions. May play a key role in signal transduction and growth control. {ECO:0000269|PubMed:16456543}.;
- Pathway
- Cell adhesion molecules (CAMs) - Homo sapiens (human);Adherens junction - Homo sapiens (human);Nectin adhesion pathway
(Consensus)
Recessive Scores
- pRec
- 0.130
Intolerance Scores
- loftool
- 0.421
- rvis_EVS
- -2.03
- rvis_percentile_EVS
- 1.7
Haploinsufficiency Scores
- pHI
- 0.206
- hipred
- Y
- hipred_score
- 0.708
- ghis
- 0.577
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.617
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ptprm
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); muscle phenotype;
Gene ontology
- Biological process
- negative regulation of endothelial cell proliferation;protein dephosphorylation;homophilic cell adhesion via plasma membrane adhesion molecules;signal transduction;negative regulation of endothelial cell migration;retina layer formation;negative regulation of angiogenesis;neuron projection development;retinal ganglion cell axon guidance;peptidyl-tyrosine dephosphorylation;response to drug;positive regulation of blood vessel diameter
- Cellular component
- cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction;cell-cell adherens junction;lamellipodium;perinuclear region of cytoplasm
- Molecular function
- protein tyrosine phosphatase activity;transmembrane receptor protein tyrosine phosphatase activity;protein binding;identical protein binding;cadherin binding